These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 20512998)

  • 1. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
    Reverter E; Blasi A; Abraldes JG; Martínez-Palli G; Seijo S; Turon F; Berzigotti A; Balust J; Bosch J; García-Pagán JC
    Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free Hepatic Vein Pressure Is Not Useful to Calculate the Portal Pressure Gradient in Cirrhosis: A Morphologic and Hemodynamic Study.
    Rössle M; Blanke P; Fritz B; Schultheiss M; Bettinger D
    J Vasc Interv Radiol; 2016 Aug; 27(8):1130-7. PubMed ID: 27212121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!
    Merkel C; Montagnese S
    Eur J Intern Med; 2011 Feb; 22(1):1-4. PubMed ID: 21238883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.
    Monescillo A; Martínez-Lagares F; Ruiz-del-Arbol L; Sierra A; Guevara C; Jiménez E; Marrero JM; Buceta E; Sánchez J; Castellot A; Peñate M; Cruz A; Peña E
    Hepatology; 2004 Oct; 40(4):793-801. PubMed ID: 15382120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
    Escorsell A; Bordas JM; Castañeda B; Llach J; García-Pagán JC; Rodés J; Bosch J
    Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
    González A; Augustin S; Pérez M; Dot J; Saperas E; Tomasello A; Segarra A; Armengol JR; Malagelada JR; Esteban R; Guardia J; Genescà J
    Hepatology; 2006 Oct; 44(4):806-12. PubMed ID: 17006916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
    Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
    Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
    Albillos A; Bañares R; González M; Ripoll C; Gonzalez R; Catalina MV; Molinero LM
    Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of portal pressure.
    Abraldes JG; Sarlieve P; Tandon P
    Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.